DEF 14A: Flora Growth Corp. Seeks Shareholder Approval for Key Proposals at 2025 Annual Meeting

Flora Growth Corp. is set to hold its 2025 Annual and Special Meeting of Shareholders on June 30, 2025, seeking approval for several key proposals including director elections, auditor re-appointment, an amendment to the incentive compensation plan, stock appreciation rights grants, a share consolidation, and repricing of outstanding SARs.

Summary

• Flora Growth Corp. will hold its 2025 Annual and Special Meeting of Shareholders on June 30, 2025, in Toronto.
• Shareholders will vote on the election of four director nominees, the re-appointment of Davidson & Company LLP as auditors, and an amendment to the 2022 Incentive Compensation Plan to increase the number of issuable shares from 2,500,000 to 4,500,000.
• The meeting will also address the approval of Stock Appreciation Rights (SARs) for the CEO, CFO, and Executive Chairman.
• A proposal to authorize the Board to effect a share consolidation at a ratio between 10:1 and 100:1 will be considered.
• Shareholders will also vote on the repricing and amendment of vesting terms for certain outstanding SARs granted to employees and executive officers.
• The Board recommends voting 'FOR' all proposals.
• The record date for determining shareholders eligible to vote is May 30, 2025.
• The company had 22,568,653 Common Shares issued and outstanding as of May 2, 2025.

Sentiment

Score: 6

Explanation: The document is neutral in tone, presenting necessary information for shareholders to make informed decisions. While it highlights positive goals, it also acknowledges risks and challenges.

Positives

• The proposed amendments to the incentive plan and grant of SARs aim to align management's interests with those of shareholders.
• The share consolidation is intended to increase the share price to meet Nasdaq's continued listing requirements.
• The company is taking steps to ensure it remains listed on the Nasdaq Capital Market, which could improve investor confidence.

Negatives

• The company has a history of net losses and limited operating history.
• The company is seeking shareholder approval for a share consolidation, which may be a sign of financial distress.
• The company is an emerging growth company and a smaller reporting company, which means it has reduced disclosure requirements.

Risks

• The company's ability to continue as a going concern is dependent on access to sources of liquidity.
• Changes in cannabis laws and regulations could adversely affect the company's business.
• The company faces risks associated with product liability claims and product recalls.
• The company's expansion into new jurisdictions is subject to regulatory compliance risks.
• Potential delisting from Nasdaq could result in reduced liquidity of the company's Common Shares.

Future Outlook

The company aims to increase its share price and market capitalization, with goals tied to executive compensation.

Management Comments

• Thank you for your continued investment in Flora Growth Corp.', said Clifford Starke, Chief Executive Officer.

Industry Context

The document highlights the competitive landscape for talent in the cannabis industry and the need for equity-based compensation to attract and retain qualified personnel.

Comparison to Industry Standards

• Verano Holdings Corp., where Sammy Dorf was formerly Chief Growth Officer, is a vertically integrated United States cannabis company with revenues exceeding $925 million.
• The document mentions that the company is an 'emerging growth company' and a 'smaller reporting company', which means it has reduced disclosure requirements compared to larger, more established companies.

Management Changes

Related Party Transactions

• On January 30, 2025, the Company purchased 100% of the issued and outstanding common shares of United Beverage Distribution Inc, a distributor of cannabis-infused drinks.
• Clifford Starke and Sammy Dorf, directors of Flora, and Dany Vaiman, Flora's Chief Financial Officer, were among the sellers.
• The consideration included 923,744 Common Shares and promissory notes with five year maturities that accrue interest at a rate of 6% per annum in an aggregate principal amount of $2,845,700.

Stakeholder Impact

• Shareholders will be impacted by the decisions made at the Annual Meeting, including the election of directors, the share consolidation, and the approval of executive compensation plans.
• Employees and executive officers may be impacted by the repricing of SARs and the amendment of vesting terms.
• The company's ability to maintain its listing on Nasdaq could impact investor confidence and the liquidity of the company's Common Shares.

Next Steps

• Shareholders to vote on the proposals at the Annual and Special Meeting on June 30, 2025.
• Board to determine whether to implement the share consolidation within one year of shareholder approval.
• Company to file a Form 8-K within four business days of the Annual Meeting to announce the voting results.

Key Dates

Keywords

shareholders, consolidation, compensation, directors, auditors, incentive, shares, proxy, Flora